Immunomedics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.03.17	Immunomedics Announces Publication of Results in Journal of Clinical Oncology, Demonstrating Treatment With Sacituzumab Govitecan (IMMU-132) Produces Early and Durable Responses in Patients With... (PR Newswire)
10.03.17	Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM... (RTTNews)
03.03.17	Immunomedics Board Institutes Measures As Stockholder Fiduciaries To Preserve Their Best Business Judgment To Protect The Rights Of All Stockholders (PR Newswire)
01.03.17	Biotech Stocks Under Scanner -- Immunomedics, Peregrine Pharma, Vericel, and Biogen (PR Newswire)
13.02.17	ICPT Catches Investors' Eyes, TCON Abuzz, IMMU Inks $2Bln Deal With SGEN (RTTNews)
10.02.17	Immunomedics Announces Postponement of 2016 Annual Meeting (PR Newswire)
10.02.17	Immunomedics Reaches Deal With Seattle Genetics For Sacituzumab Govitecan (RTTNews)
10.02.17	Immunomedics Enters into Exclusive Global Licensing Agreement with Seattle Genetics for Sacituzumab Govitecan (IMMU-132) with Potential Payments of up to Approximately $2 Billion, Plus Royalties (PR Newswire)
19.01.17	DERM Delights With A Hat-trick, Shot In The Arm For APRI, FDA Nod For TEVA (RTTNews)
13.01.17	Gainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI (RTTNews)
09.01.17	Immunomedics CEO Cynthia Sullivan To Step Down In Mid-2017 - Quick Facts (RTTNews)
29.11.16	Technical Reports on Biotech Stocks -- Juno Therapeutics, Immunomedics, Cempra, and Neuralstem (PR Newswire)
26.02.16	SGYP On Watchlist, BXLT Seeks New Use For Hemophilia Drug, ZTS Gets FDA Nod (RTTNews)
26.02.16	Immunomedics Announces Termination Of Epratuzumab Licensing Deal With UCB (RTTNews)
08.02.16	Trouble For CTIC, It's A Thumbs Up For BMY, CYCC On Notice Again, VRTX Snubbed (RTTNews)
20.08.15	MCUR's VLU Trial Is Futile, CRBP, CEMP On Fast Track, INO Takes A Shot At MERS (RTTNews)
04.08.15	Immunomedics Says FDA Grants Orphan Drug Status For Veltuzumab To Treat ITP (RTTNews)
18.05.15	MOH Opens Wallet, IMMU Fast Tracked, OVAS Continues To Deliver (RTTNews)
20.02.15	Mark Your Calendar For TCON, XLRN, Xenon Lights Up, MACK Gets Going (RTTNews)
05.01.15	Immunomedics: Sacituzumab Govitecan Awarded FDA Fast Track Designation (RTTNews)
21.11.14	FDA Grants Orphan Drug Status For Immunomedics' Veltuzumab To Treat Pemphigus (RTTNews)
26.08.14	ADXS Makes It Big, ALKS Waiting To Face FDA, ITMN Snapped Up, KITE Flies High (RTTNews)
02.06.14	ARIA Making News, IMMU On The Move, SQNM Does A Deal, Threshold Finds MTD (RTTNews)
20.05.14	CLVS Up After-Hours, ECYT On The Back Foot, IMMU Making News, NNVC Cashed Up (RTTNews)
13.05.14	Immunomedics Announces U.S. Patent Issuance For IMMU-114 - Quick Facts (RTTNews)
02.05.14	Immunomedics Prices Public Offering Of 9 Mln Shares At $3.35/shr - Quick Facts (RTTNews)
08.04.14	Immunomedics Reports Preclinical Results On SN-38 ADCs - Quick Facts (RTTNews)
08.04.14	IMMU Chugs Along, MNKD Decision Delayed, QCOR Bought Out, Another First For ISR (RTTNews)
07.04.14	Immunomedics Reports Results From Three Phase I Trials With IMMU-130 (RTTNews)
04.12.13	Immunomedics' IMMU-132 Gets Orphan Drug Status For Small Cell Lung Cancer (RTTNews)
24.10.13	AGN's Filler Gets FDA Green Light, ADXS, CYTR On Watch, IMMU On The Move (RTTNews)
10.10.13	ARIA Loses Pace, DVAX On The Move, BDSI, CHTP Get FDA Dates, ACUR Buys Peace (RTTNews)
04.10.13	Positive Results, Close of Public Offerings, Grants, Data Presentations and Partnerships - Research Report on Lexicon, Sangamo Biosciences, Immunomedics, NewLink Genetics, and Pacific Biosciences (PR Newswire)
01.10.13	ACRX Files Zalviso NDA, BGMD Gets A Booster, UK's NICE Turns Nice To PSDV (RTTNews)
20.09.13	Did You Buy These Stocks? (RTTNews)
10.09.13	Acquisitions, Study Results, Product Enhancements, and New Appointments - Research Report on Astex, Boston Scientific, WellCare, ResMed, and Immunomedics (PR Newswire)
04.09.13	Immunomedics Appoints Peter Pfreundschuh As CFO (RTTNews)
29.08.13	Clinical Trials, Pipeline Developments, Financial Results, and New Appointments - Research Report on Amarin, Immunomedics, Seattle Genetics, Repros Therapeutics, and LifePoint (PR Newswire)
26.08.13	HealthCare, Technology Briefing: Market Movers for the Week - Technologies-Scan Corp, GNC, Galena Biopharma, Immunomedics, Amarin (PR Newswire)
12.08.13	Immunomedics Provides Update On Antibody-drug Conjugate Trials - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’059.00	2.92 %	K V
Logitech Intl	94.36	2.03 %	K V
Part Grp Hldg	1’422.50	1.07 %	K V
Sika	242.10	0.71 %	K V
Holcim	98.62	0.39 %	K V
Roche Hldg G	294.50	-1.11 %	K V
Kuehne+Nagel Int	209.20	-1.13 %	K V
Nestle	82.48	-1.43 %	K V
Swisscom	499.80	-2.00 %	K V
Novartis	95.37	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Immunomedics Inc.

Aktien Top/Flop

Immunomedics Peer Group Nachrichten

Meistgelesene Nachrichten